Answer
The centre must safely identify, store and administer the personalised cells and promptly recognise and treat serious complications such as cytokine release syndrome and neurological toxicity.
Sources for this answer
- Breyanzi 1.1-70 × 10^6 cells/mL / 1.1-70 × 10^6 cells/mL dispersion for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.